Farrell Simon

Insider Reports History

Location: C/O Trevi Therapeutics, Inc., 195 Church Street, Floor 14, New Haven, CT
Signature: /s/ Christopher Galletta, attorney-in-fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Farrell Simon:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Trevi Therapeutics, Inc.	Chief Commercial Officer	Common Stock	76.9K	$550K	$7.15	Mar 10, 2025	Direct
Trevi Therapeutics, Inc.	Chief Commercial Officer	Performance Stock Option (right to buy)	110K			May 31, 2025	Direct
Trevi Therapeutics, Inc.	Chief Commercial Officer	Stock Option (right to buy)	18.8K			Mar 10, 2025	Direct

Showing 1 to 3 of 3 entries

Insider Reports Filed by Farrell Simon

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
TRVI	Trevi Therapeutics, Inc.	May 31, 2025	1	$0	4	Jun 3, 2025	Chief Commercial Officer
TRVI	Trevi Therapeutics, Inc.	Mar 10, 2025	9	-$227K	4	Mar 12, 2025	Chief Commercial Officer
TRVI	Trevi Therapeutics, Inc.	Feb 18, 2025	1	$0	4	Feb 20, 2025	Chief Commercial Officer
TRVI	Trevi Therapeutics, Inc.	Feb 15, 2024	1	$0	4	Feb 16, 2024	Chief Commercial Officer
TRVI	Trevi Therapeutics, Inc.	Jun 20, 2023	2	$3.19K	4	Jun 21, 2023	Chief Commercial Officer
TRVI	Trevi Therapeutics, Inc.	Mar 7, 2023	2	$9.58K	4	Mar 8, 2023	Chief Commercial Officer
TRVI	Trevi Therapeutics, Inc.	Feb 16, 2023	1	$0	4	Feb 16, 2023	Chief Commercial Officer
TRVI	Trevi Therapeutics, Inc.	Feb 16, 2023	0	$0	3	Feb 16, 2023	Chief Commercial Officer